Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$81.08 - $119.29 $152 Million - $224 Million
-1,875,671 Reduced 80.92%
442,403 $44.1 Million
Q3 2023

Nov 14, 2023

SELL
$115.27 - $182.23 $8.34 Million - $13.2 Million
-72,323 Reduced 3.03%
2,318,074 $276 Million
Q2 2023

Aug 14, 2023

SELL
$161.03 - $209.15 $4.66 Million - $6.06 Million
-28,967 Reduced 1.2%
2,390,397 $426 Million
Q1 2023

May 15, 2023

SELL
$153.15 - $198.21 $591,771 - $765,883
-3,864 Reduced 0.16%
2,419,364 $399 Million
Q4 2022

Feb 14, 2023

SELL
$136.25 - $165.56 $7.58 Million - $9.21 Million
-55,633 Reduced 2.24%
2,423,228 $382 Million
Q3 2022

Nov 14, 2022

BUY
$149.44 - $188.1 $370 Million - $466 Million
2,478,861 New
2,478,861 $373 Million

Others Institutions Holding ICUI

About ICU MEDICAL INC


  • Ticker ICUI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 23,899,400
  • Market Cap $3.5B
  • Description
  • ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...
More about ICUI
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.